603579 荣泰健康
2026/03 - 三个月2025/122024/122023/122022/12

盈利能力分析
净资产收益率 ROE (%)2.4696.2809.63810.5719.017
总资产报酬率 ROA (%)1.8944.1205.3865.9544.901
投入资产回报率 ROIC (%)2.2294.8406.3596.9785.977

边际利润分析
销售毛利率 (%)30.93930.72731.68030.54726.524
营业利润率 (%)15.27811.69413.17612.7209.304
息税前利润/营业总收入 (%)16.25512.86612.15311.6067.877
净利润/营业总收入 (%)15.6459.53612.01210.9618.216

收益指标分析
经营活动净收益/利润总额(%)30.03529.03777.07092.71298.252
价值变动净收益/利润总额(%)56.05957.31815.5715.66716.715
营业外收支净额/利润总额(%)-0.0080.269-0.194-2.504-3.994

偿债能力分析
流动比率 (X)2.8503.0862.2103.3422.551
速动比率 (X)2.5802.8672.0563.1252.320
资产负债率 (%)23.59921.98646.13641.71245.380
带息债务/全部投入资本 (%)8.4445.66433.88226.70334.941
股东权益/带息债务 (%)1,054.1191,618.449186.444258.827180.349
股东权益/负债合计 (%)320.345354.463116.664139.450120.110
利息保障倍数 (X)16.60811.274-12.191-14.461-7.362

营运能力分析
应收账款周转天数 (天)40.75844.72340.22424.10321.344
存货周转天数 (天)55.06850.58748.94248.90759.238